Literature DB >> 33498637

Clinical Utility of Increased Nuchal Translucency at 11-13 Weeks of Gestation in Twin Pregnancies Based on the Chorionicity.

SiWon Lee1, Hyun-Mi Lee2, You Jung Han3, Moon Young Kim3, Hye Yeon Boo2, Jin Hoon Chung4.   

Abstract

To assess clinical implications of increased nuchal translucency (INT) in twin pregnancies based on the chorionicity. This was a retrospective review of the twin pregnancies who underwent first trimester ultrasound with nuchal translucency (NT) measurement at 11-13 weeks of gestation from January 2006 to December 2014. Data were collected using the OB database and the chart review. Pregnancy outcomes, including gestational weeks at the delivery, abnormal fetal karyotypes, fetal structural anomalies, and twin-specific complications, were analyzed. A total of 1622 twin pregnancies with INT ≥ 95th percentile in one or both fetuses were identified. In all twin pregnancies with INT, abnormal fetal karyotypes were identified in 17 (8.6%) patients (odds ratio = 13.28, CI = 5.990-29.447, p = 0.000) and twin-specific complications were identified in 23 (11.6%) patients (odds ratio = 2.398, CI = 1.463-3.928, p = 0.001) compared to those with normal NT. Among the INT group, when the groups were subdivided into monochorionic (MC) and dichorionic (DC) pregnancies, 14.8% and 29.6% of the MC pregnancies had structural anomalies in one or both fetuses (odds ratio = 5.774, 95% CI = 1.445-23.071, p = 0.01) and twin-specific complications (odds ratio = 4.379, 95% CI = 1.641-11.684, p = 0.03), respectively, compared to DC pregnancies with 2.9% for structural anomalies and 8.8% for twin-specific complications. The prevalence of abnormal fetal karyotypes was not statistically different in patients with INT when compared between MC and DC pregnancies (p = 0.329). INT was associated with a higher rate of twin-specific complications and fetal structural anomalies in MC twin pregnancies rather than abnormal fetal karyotype. Therefore, NT measurement in MC twin pregnancies can be a useful tool for predicting adverse pregnancy outcomes. Appropriate counseling and surveillance based on the chorionicity are imperative in the prenatal care of twin pregnancies.

Entities:  

Keywords:  anomaly; chorionicity; nuchal translucency; twin complications; twin pregnancy

Year:  2021        PMID: 33498637      PMCID: PMC7865212          DOI: 10.3390/jcm10030433

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  24 in total

Review 1.  The management of multiple pregnancy.

Authors:  Myles J O Taylor
Journal:  Early Hum Dev       Date:  2006-05-04       Impact factor: 2.079

2.  Difference in nuchal translucency between monozygotic and dizygotic spontaneously conceived twins.

Authors:  Po-Jen Cheng; Shang-Yu Huang; Sheng-Wen Shaw; Ching-Hwa Hsiao; Chuan-Chi Kao; Ho-Yen Chueh; T'sang-T'ang Hsieh
Journal:  Prenat Diagn       Date:  2010-03       Impact factor: 3.050

3.  Screening for trisomy 21 in twin pregnancies by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation.

Authors:  N J Sebire; R J Snijders; K Hughes; W Sepulveda; K H Nicolaides
Journal:  Br J Obstet Gynaecol       Date:  1996-10

4.  Increased nuchal translucency thickness at 10-14 weeks of gestation as a predictor of severe twin-to-twin transfusion syndrome.

Authors:  N J Sebire; C D'Ercole; K Hughes; M Carvalho; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  1997-08       Impact factor: 7.299

Review 5.  Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.

Authors:  M M Gil; S Galeva; J Jani; L Konstantinidou; R Akolekar; M N Plana; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2019-06-04       Impact factor: 7.299

Review 6.  Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.

Authors:  M M Gil; V Accurti; B Santacruz; M N Plana; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2017-07-27       Impact factor: 7.299

7.  Increased nuchal translucency at 11-13 weeks' gestation and outcome in twin pregnancy.

Authors:  B Cimpoca; A Syngelaki; E Litwinska; A Muzaferovic; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2020-02-13       Impact factor: 7.299

Review 8.  Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: another double trouble.

Authors:  Ron Maymon; Ortal Neeman; Adrian Shulman; Hadar Rosen; Arie Herman
Journal:  Prenat Diagn       Date:  2005-09       Impact factor: 3.050

9.  Routine first-trimester screening for fetal trisomies in twin pregnancy: cell-free DNA test contingent on results from combined test.

Authors:  S Galeva; L Konstantinidou; M M Gil; R Akolekar; K H Nicolaides
Journal:  Ultrasound Obstet Gynecol       Date:  2018-12-07       Impact factor: 7.299

Review 10.  First trimester screening for Down syndrome in multiple pregnancy.

Authors:  Jane Cleary-Goldman; Richard L Berkowitz
Journal:  Semin Perinatol       Date:  2005-12       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.